Search -

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

Higher Chili Pepper Consumption Linked to Fewer CVD Deaths

L.A. McKeown

December 17, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

No Benefit of Colchicine in All-Comers PCI

Shelley Wood

November 17, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Michael O'Riordan

October 22, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

Todd Neale

August 01, 2019

News Conference News SCCT 2019

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Yael L. Maxwell

July 15, 2019

News Conference News SCCT 2019

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Yael L. Maxwell

July 12, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways

Michael O'Riordan

July 05, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

Advertisement

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Higher Chili Pepper Consumption Linked to Fewer CVD Deaths

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

No Benefit of Colchicine in All-Comers PCI

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Recurrent Events Common Among Young Patients With CAD

Strokes Increasing in STEMI Patients With Cardiogenic Shock

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content